Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Gabelli Gold a Solid Pick

GGN provides a steady dividend return and a way to participate in major metals mining stocks.

Stifel (SF) Performance Encourages Investors

Coming in the face of earnings stress at most other financial services firms, Stifel Financial's (SF) fourth-quarter report was greeted warmly by investors.

Olin Basing, Setting Up for a Move

OLN has a short-term trading target, but it could be a quality long-term chemical holding.

Applied Materials (AMAT): It’s Not Easy Being Green

Applied Materials Inc. (AMAT) underscored just how weak the economy is earlier this week when it posted its first quarterly loss in five years and said it planned to cut both production and jobs.

Is Marsh & McLennan (MMC) A Recession Stock?

Since January 1st, Marsh & McLennan (MMC) has been subject to some of the wildest swings in price for any stock so far this year.

Nvidia (NVDA) Chips Not Selling

Graphics chipmaker Nvidia Corp. (NVDA) said on Wednesday that its revenue plunged 60 percent in the fourth quarter to $481.1 million from $1.2 billion a…

Newmont Mining (NEM): Protect Against Hyper-Inflation

The stock price is not cheap at the current level, but investors seeking an investment likely to perform well during hyper-inflation may wish to consider including a mining company like Newmont (NEM) in their portfolio.

Stimulus Opportunity: Manitowoc (MTW) Bonds

There is no doubt that MTW is feeling the pain of a fractured economy. It is also clear that MTW's position in the marketplace for their products positions them well for the economic stimulus package. Their Corporate Bonds also offer an attractive yield.

Give These 5 Sectors a Second Chance

Investors have certainly fallen out of love with stocks during the course of this financial crisis. But with most companies so beaten down, it may be time to show a select few our love. While each of these sectors is currently out of favor, there are a number of stocks within each one that could be worth courting. It may take time to repair the damage, but our portfolios should be rewarded for giving these companies a second chance.

5 Bargain Stocks to Buy Now

Stocks are cheap, and they're on sale. Here are 5 bargains to buy now.

Despite Sell-off, S&P Says to Stay Long

With the SPX sitting just above its 900-820 support zone, we will stay long and cautiously add to oversold positions.

A Foursquare Trade in Cubic Corp.

Since its October low, CUB has established a chart pattern that is close to perfect.

Rohm and Hass (ROH) Sales Down 13 Percent

Rohm and Haas Company (ROH) announced on Monday that its fourth-quarter earnings fell to $32 million or 17 cents per share from $180 million, or 91 cents per share from a year ago.

Whirlpool Corp. (WHR): Better Days Ahead?

After two years of decimation in the homebuilding sector is Whirlpool (WHR) now worthy of investment consideration?

Weekly Credit Market Report

Economic reports released this past week is further evidence that the economy continues in its recessionary mode.

Akamai (AKAM) Performs Beyond Expectations

Shares of Akamai Technologies Inc. (AKAM) surged 18 percent higher on Thursday after the company's fourth quarter earnings report beat Wall Street's expectations.

Investors Take Profits on Dollar Tree

Apparently investors believe that now is the time to get out of their positions in Dollar Tree, Inc. (DLTR). How else does one explain the…

Show Me the Money: 5 Top Investing Ideas

Many investors have simply given up on the markets in light of the huge losses during the last year or so. But for those brave souls who are persevering, now is the time for opportunity. And the Money Show is a great place to find ideas that can propel your portfolio forward during difficult times. Here are some of the best ideas from this month's show.

Is OSI Pharmaceuticals (OSIP) a Hit or Miss?

Shares of biotech drug firm OSI Pharmaceuticals (OSIP) soared 16 percent higher on Tuesday after a late stage trial found that its cancer pill, Tarceva, when combined with Genentech's Avastin, extended the time patients with advanced lung cancer lived without the disease getting worse.